Trendora

Co-Scientist

Assess

Platforms

A multi-agent AI research partner for accelerating scientific discovery.

Why it's here

Placed in Assess: 6 article(s) of evidence from 1 source(s), led by research-stage coverage, with 0 in the last 30 days. Confidence 42%.

Evidence (6)

  • 7Google DeepMind·5/18/2026research
    Google DeepMind launches Co-Scientist to speed genetic discovery

    Google DeepMind announced Co-Scientist, a multi-agent AI partner designed to accelerate scientific research. The system is presented as a way to help identify genetic leads that may support efforts to reverse cellular aging, with details shared alongside a Science publication.

  • 7Google DeepMind·5/16/2026research
    Co-Scientist Aims to Find Molecular Switches Behind New Infectious Diseases

    Google DeepMind highlights Co-Scientist, a multi-agent AI partner designed to accelerate scientific research. The item points to its use in studying the molecular switches involved in emerging infectious diseases, with a Science reference dated May 2026. The announcement frames the system as a research accelerator rather than a finished medical product.

  • 6Google DeepMind·5/16/2026research
    DeepMind launches Co-Scientist for aging research

    Google DeepMind highlights Co-Scientist, a multi-agent AI partner designed to help accelerate scientific research. The announcement is tied to aging research and was presented in Science in May 2026.

  • 6Google DeepMind·5/16/2026research
    Google DeepMind’s Co-Scientist aims to speed up liver disease research

    Google DeepMind is highlighting Co-Scientist, a multi-agent AI system designed to assist scientific research. In this item, the focus is on using the system to accelerate discovery of liver disease mechanisms, with a Science publication noted for May 2026. The announcement frames the work as a research tool rather than a consumer product or model release.

  • 6Google DeepMind·5/16/2026research
    DeepMind links biological toolkits for ALS research

    Google DeepMind highlights a new research approach for amyotrophic lateral sclerosis (ALS) that unites multiple biological toolkits. The item points to Co-Scientist, a multi-agent AI partner designed to accelerate scientific discovery, with the work appearing in Science in May 2026.

  • 7Google DeepMind·5/12/2026research
    Google DeepMind's Co-Scientist helps find liver fibrosis drug candidates

    Google DeepMind says its multi-agent system Co-Scientist helped accelerate research on liver fibrosis by surfacing overlooked drug-repurposing candidates. One candidate blocked 91% of a scarring-linked response in lab tests, and the findings were published in Advanced Science. The work suggests AI-assisted gene-regulating approaches may help identify new treatments for chronic liver disease.